CBAY News
Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens
Gilead posts quarterly loss on acquisition charge, revenue rises 5% By Reuters
Gilead completes CymaBay acquisition but negative impact on 2024 EPS
Guru Fundamental Report for CBAY
Gilead Sciences Announces Expiration Of HSR Waiting Period For CymaBay Tender Offer
Guru Fundamental Report for CBAY
Director Janet Dorling Sells 6,000 Shares of CymaBay Therapeutics Inc (CBAY)
M & A News: Gilead (NASDAQ:GILD) to Acquire CymaBay
CBAY Events
No data
CBAY Monitor News
No data
CBAY Earnings Analysis